Magdalena Harris
HIT Hot Topics

2014 Conference

Liverpool, 25 November 2016

On the 14th of November 2014 we held the fourth annual Hot Topics Conference, it was as always an amazing event with some of the most inspiring speakers we could find. This page contains the presentations from the day including video footage so even if you didn’t get to attend you can benefit from the knowledge shared.

Dr Carl Hart

High Price

Carl Hart

Carl Hart is the author of the book ‘High Price: A Neuroscientist’s Journey of Self-Discovery That Challenges Everything You Know About Drugs and Society’. He is an associate professor in the departments of Psychology and Psychiatry at Columbia University. He is also a research scientist in the Division of Substance Abuse at the New York State Psychiatric Institute. Dr. Hart is a member of the National Advisory Council on Drug Abuse and on the board of directors of the College on Problems of Drug Dependence and the Drug Policy Alliance. A native of Miami, Florida, Dr. Hart received his BS in psychology at the University of Maryland and his MS and PhD in experimental psychology and neuroscience at the University of Wyoming.

Carl talked about his work and the perceptions of drug use and drug users in society.

Anne-Marie Cockburn

5,742 days

Anne-Marie Cockburn

Carl Hart is the author of the book ‘High Price: A Neuroscientist’s Journey of Self-Discovery That Challenges Everything You Know About Drugs and Society’. He is an associate professor in the departments of Psychology and Psychiatry at Columbia University. He is also a research scientist in the Division of Substance Abuse at the New York State Psychiatric Institute. Dr. Hart is a member of the National Advisory Council on Drug Abuse and on the board of directors of the College on Problems of Drug Dependence and the Drug Policy Alliance. A native of Miami, Florida, Dr. Hart received his BS in psychology at the University of Maryland and his MS and PhD in experimental psychology and neuroscience at the University of Wyoming.

Carl talked about his work and the perceptions of drug use and drug users in society.

David Stuart

Sexualised use of novel psycoactive drugs among gay men

David Stuart

David Stuart is the Substance Use Lead at 56 Dean street, GUM/ HIV (Chelsea and Westminster hospital, NHS Foundation Trust), a role created specifically to address the UK syndemic of HIV/HCV/ STI/sexualized drug use by MSM, often referred to as “ChemSex”. David has been instrumental in promoting understanding and good practice in the field of MSM substance use, facilitating the adoption of substance use work within the GUM/HIV sector to address ChemSex trends.

David presented about the adoption of novel psychoactive drugs (particularly Mephedrone, methamphetamine and GHB/GBL) by gay/bisexual men to facilitate sex and the impact this has on the way services work with people.

Prof. Gerry Stimson

Electronic cigarette: disruptive technology, public health potential and regulatory challenge

Prof. Gerry Stimson

Gerry is a public health social scientist, with over 40 years’ experience of public health research and advocacy in the field of psychoactive substance use. He was one of the founders of harm reduction in the 1980s, and much of his academic research focused on reducing drug and alcohol related harms. Now an ardent e-cigarette advocate. He is Honorary Professor at the London School of Hygiene and Tropical Medicine, Emeritus Professor at Imperial College London, and the Editor of the International Journal of Drug Policy. He founded the Department of Social Science and Medicine at Imperial College. From 1990 to 2004, he was Director of the Centre for Research on Drugs and Health Behaviour. He was Executive Director of the International Harm Reduction Association from 2004 to 2010.

Gerry spoke about electronic cigarettes and the role they play within public health.

Dr. Magdalena Harris

An elephant in the room? The role of pragmatics and pleasure in effective harm reduction

Dr Magdalena Harris

Dr Magdalena Harris is a qualitative sociologist based at the Centre for Research on Drugs and Health Behaviour, London School of Hygiene & Tropical Medicine. After devoting her 20’s to heroin and other injecting drug use in New Zealand, Magdalena returned to University graduating with a PhD from the University of New South Wales, Australia. She has been based in London for the past five years, conducting a programme of research investigating the lived experience of hepatitis C and its treatment in the UK. Magdalena has published widely on harm reduction and hepatitis C, is a UK Hepatitis C Trust board member, editorial board member for the International Journal of Drug Policy and is passionate about community engagement and building links between community/activist organisations and social research institutions/academia.

Magdalena spoke about understanding the role pleasure plays when working with people who use drugs.

Katy MacLeod

What’s trending? – New drugs, new populations

Katy MacLeod

Katy MacLeod is the National Training and Development Officer for the Scottish Drugs Forum. She coordinates the New Psychoactive Substances (NPS) and psychostimulant work for the organisation. Katy is also Director at Safe & Sound Welfare where she works literally ‘out in the field’ at various music festivals and events. In this role she conducts research into drug prevalence and coordinates welfare services providing information, advice and support to drug users or those considering using substances.

Katy gave an update on the latest NPS and psychostimulant drug trends and the role of harm reduction within specific populations of concern from ‘recreational’ users through to people who inject drugs.

Sara McGrail

Fast forward?

Sara McGrail

Sara McGrail is a long time commentator on UK drug policy – particularly in terms of commissioning and treatment policy. She has worked in the sector for more years than she cares to remember – having been inducted into the mysteries of outreach work and needle exchange on the streets of Croxteth and Norris Green in the early 90s. Since then she has worked in central and local government, in senior roles in treatment providers and most happily as a freelance policy advisor. She now divides her time equally between the drugs field, and work on personalisation and advocacy with a much broader client group.

Sara gave an overview of the signals coming from the main parties in next years general election in terms of health and social care, money, CJ policy. She also looked at what this might mean for the people who use and work in drug services.

Russell Newcombe

Intoxiphobia: a review of the international literature on discrimination against people who use drugs

Russell Newcombe

Russell Newcombe has been doing research and training on drug use and drug services for 30 years. His books include ‘Living with Heroin’ (co-author 1988), ‘The Reduction of Drug-Related Harm’ (co-editor 1992), and ‘Tripology’ (2004). Since 2010, Russell has been running 3D Research, specializing in research and training on novel psychoactive substances (NPS) and evaluation of harm-reduction interventions.

Russell spoke about the stigmatization of and discrimination against people who use drugs, i.e. negative attitudes and behaviour from both organisations and individuals toward users of prohibited drugs.

Jon Derricott

Video Credits

All the films of sessions appearing on this page have been recorded and edited by Jon Derricott.

HIT Hot Topics

Gallery

Contact

  • Write
    HIT
    9/24 Argyle Street
    Liverpool
    L1 5DL
  • Call  
    0151 702 0630
  • Email
    stuff@hit.org.uk

HIT Newsletter

© HIT 1985
Registered address: The Foundry,
38 Henry Street, Liverpool, L1 5BS

This site is protected by reCAPTCHA and the Google
Privacy Policy and Terms of Service apply.